ストックスクリーナーアプリを入手
125.17
0.61%
0.76
前日終値:
$124.41
開ける：
$124.29
24時間の取引高:
506.62K
Relative Volume:
0.80
時価総額：
$6.25B
収益：
$338.46M
当期純損益:
$-310.96M
株価収益率:
-19.17
EPS:
-6.53
ネットキャッシュフロー:
$-132.82M
1週間 パフォーマンス:
+3.21%
1か月 パフォーマンス:
+20.83%
6か月 パフォーマンス:
+0.06%
1年 パフォーマンス:
+33.60%
1日の値動き範囲:
$122.56
$125.25
1週間の範囲:
$120.72
$125.25
52週間の値動き範囲:
$75.56
$139.13
Axsome Therapeutics Inc Stock (AXSM) Company Profile
名前
Axsome Therapeutics Inc
セクター
電話
(212) 332-3241
住所
ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK
AXSM を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AXSM
Axsome Therapeutics Inc
|
125.17 | 6.21B | 338.46M | -310.96M | -132.82M | -6.53 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Axsome Therapeutics Inc Stock (AXSM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-03 | 再開されました | Wells Fargo | Overweight |
| 2025-07-03 | 再開されました | Morgan Stanley | Overweight |
| 2025-06-03 | 開始されました | Oppenheimer | Outperform |
| 2025-04-07 | 開始されました | Jefferies | Buy |
| 2025-02-11 | 開始されました | Deutsche Bank | Buy |
| 2024-12-31 | 繰り返されました | Mizuho | Outperform |
| 2024-09-03 | 開始されました | Wells Fargo | Overweight |
| 2024-08-06 | アップグレード | BofA Securities | Neutral → Buy |
| 2024-07-22 | 開始されました | Needham | Buy |
| 2024-04-29 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2024-03-19 | 開始されました | Robert W. Baird | Outperform |
| 2024-02-06 | 開始されました | UBS | Buy |
| 2024-01-25 | 開始されました | RBC Capital Mkts | Outperform |
| 2023-12-13 | 開始されました | Citigroup | Buy |
| 2023-08-08 | アップグレード | BofA Securities | Underperform → Neutral |
| 2023-01-05 | 開始されました | Piper Sandler | Neutral |
| 2022-11-01 | 開始されました | Loop Capital | Buy |
| 2022-09-07 | 再開されました | Mizuho | Buy |
| 2021-08-10 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2021-06-10 | 開始されました | Berenberg | Buy |
| 2021-01-08 | 開始されました | Jefferies | Buy |
| 2020-12-16 | 開始されました | Mizuho | Buy |
| 2020-09-29 | 開始されました | BofA Securities | Underperform |
| 2020-09-10 | 開始されました | Morgan Stanley | Overweight |
| 2020-04-28 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-04-14 | 開始されました | Cowen | Outperform |
| 2019-12-30 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-12-17 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-12-16 | 繰り返されました | Guggenheim | Buy |
| 2019-10-16 | 開始されました | Guggenheim | Buy |
| 2019-09-18 | 開始されました | William Blair | Outperform |
| 2019-05-28 | 開始されました | SunTrust | Buy |
| 2019-05-23 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-04-08 | 開始されました | SVB Leerink | Outperform |
| 2019-03-15 | 繰り返されました | H.C. Wainwright | Buy |
| 2016-10-03 | 再開されました | Brean Capital | Buy |
| 2015-12-15 | 開始されました | Cantor Fitzgerald | Buy |
| 2015-12-14 | 開始されました | Ladenburg Thalmann | Buy |
すべてを表示
Axsome Therapeutics Inc (AXSM) 最新ニュース
Point72 Europe London LLP Has $1.76 Million Stake in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Russell Investments Group Ltd. Trims Position in Axsome Therapeutics, Inc. $AXSM - MarketBeat
PDT Partners LLC Increases Stake in Axsome Therapeutics, Inc. $AXSM - MarketBeat
What does recent volatility data suggest for Axsome Therapeutics Inc2025 Key Lessons & Reliable Breakout Forecasts - Newser
Cormorant Asset Management LP Trims Stock Holdings in Axsome Therapeutics, Inc. $AXSM - MarketBeat
What does recent volatility data suggest for Axsome Therapeutics Inc.July 2025 Analyst Calls & Weekly Stock Breakout Alerts - Newser
Ieq Capital LLC Purchases New Holdings in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Axsome therapeutics director Saad sells $1.14 million in shares By Investing.com - Investing.com Australia
Axsome therapeutics director Saad sells $1.14 million in shares - Investing.com
Ranking Axsome Therapeutics Inc. among high performing stocks via toolsQuarterly Profit Review & High Accuracy Buy Signal Tips - Newser
Applying big data sentiment scoring on Axsome Therapeutics Inc.July 2025 PreEarnings & Weekly High Momentum Picks - Newser
Landscape Capital Management L.L.C. Makes New $632,000 Investment in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Published on: 2025-09-05 14:08:02 - Newser
Is Axsome Therapeutics Inc. a stock for growth or value investorsWeekly Profit Recap & High Conviction Buy Zone Picks - خودرو بانک
Best data tools to analyze Axsome Therapeutics Inc. stockTrade Signal Summary & Technical Pattern Alert System - Newser
Using AI based signals to follow Axsome Therapeutics Inc.July 2025 Pullbacks & Weekly High Return Opportunities - Newser
BVF Inc. IL Increases Stock Holdings in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Why Axsome Therapeutics Inc. is moving today2025 Historical Comparison & Smart Investment Allocation Tips - Newser
Custom watchlist performance reports with Axsome Therapeutics Inc.Weekly Investment Report & Fast Entry Momentum Alerts - Newser
Multi asset correlation models including Axsome Therapeutics Inc.Earnings Trend Report & High Conviction Investment Ideas - Newser
Roger Jeffs Sells 13,464 Shares of Axsome Therapeutics (NASDAQ:AXSM) Stock - MarketBeat
Axsome Therapeutics at Cantor Conference: Strategic Growth in Brain Health By Investing.com - Investing.com Canada
Driehaus Capital Management LLC Makes New Investment in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Is Axsome Therapeutics Inc.’s growth already priced inCPI Data & Safe Swing Trade Setup Alerts - khodrobank.com
Prediction: These 2 Biotech Stocks Could Double in the Next 5 Years - The Globe and Mail
Will Axsome Therapeutics Inc. bounce back from current supportWeekly Gains Summary & High Return Trade Opportunity Guides - Newser
Forecasting Axsome Therapeutics Inc. price range with options dataJuly 2025 Review & Weekly High Potential Alerts - Newser
Wells Fargo Initiates Coverage on Axsome Therapeutics with Overweight Rating and $163 Price Target - AInvest
Relative strength of Axsome Therapeutics Inc. in sector analysisQuarterly Portfolio Review & Long-Term Safe Investment Plans - Newser
Sector ETF performance correlation with Axsome Therapeutics Inc.Volume Spike & Proven Capital Preservation Methods - Newser
Using Bollinger Bands to evaluate Axsome Therapeutics Inc.Portfolio Growth Summary & Momentum Based Trading Signals - Newser
Applying chart zones and confluence areas to Axsome Therapeutics Inc.July 2025 EndofMonth & Safe Capital Growth Tips - Newser
Is now a turning point for Axsome Therapeutics Inc.Dip Buying & Verified Swing Trading Watchlist - Newser
Axsome at Wells Fargo Conference: Growth and Strategic Expansions - Investing.com
Axsome initiated with Overweight at Wells Fargo on Alzheimer's drug potential - MSN
Wells Fargo Initiates Axsome Therapeutics with Overweight Rating, $163 Price Target - AInvest
Axsome Therapeutics Insider Sold Shares Worth $7,303,400, According to a Recent SEC Filing - 富途牛牛
Why Is Axsome (AXSM) Up 19.2% Since Last Earnings Report? - ca.finance.yahoo.com
Will Axsome Therapeutics Inc. stock recover after recent dropEarnings Trend Report & Technical Buy Zone Confirmation - Newser
What to do if you’re stuck in Axsome Therapeutics Inc.Watch List & Safe Capital Investment Plans - Newser
What’s the recovery path for long term holders of Axsome Therapeutics Inc.2025 EndofYear Setup & Free Expert Verified Stock Movement Alerts - Newser
Axsome Therapeutics stock rated Overweight by Wells Fargo - Investing.com Australia
Published on: 2025-09-03 05:51:54 - Newser
Tema Etfs LLC Takes Position in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Chart based analysis of Axsome Therapeutics Inc. trendsCPI Data & Weekly Top Performers Watchlists - Newser
What’s next for Axsome Therapeutics Inc. stock price2025 Market WrapUp & Expert-Curated Trade Recommendations - Newser
What earnings revisions data tells us about Axsome Therapeutics Inc.Trade Signal Summary & Daily Oversold Stock Bounce Ideas - Newser
Published on: 2025-09-03 02:19:56 - Newser
Axsome Therapeutics Inc (AXSM) 財務データ
収益
当期純利益
現金流量
EPS
Axsome Therapeutics Inc (AXSM) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Saad Mark E | Director |
Sep 05 '25 |
Sale |
125.07 |
9,127 |
1,141,514 |
10,002 |
1.40%
大文字化:
|
ボリューム (24 時間):